Navigation Links
ReBuilder Medical Technologies, Inc. Announces New York Marketing Agreement

CHARLES TOWN, W.Va., Aug. 26 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has signed a marketing agreement for the state of New York.

(Logo: )

More than 50,000 patients suffering from pain in their legs and feet have been helped by the ReBuilder, an electrical stimulation device that the patient administers himself in the privacy of his own home for 30 minutes a day.

"By signing this deal, we have increased our visibility in this major metropolitan market," said David Phillips, Ph.D. CEO, "and since the principals are Podiatrists, they have a natural 'in' with other doctors of Podiatric Medicine."

Additionally, Dr. Phillips reported: "We will release the name of the organization in the coming weeks when they have all their PR in place and are ready to begin their roll-out. In the meantime, if doctors in the New York area want info they can call us."

Finally, Dr. Phillips told reporters today: "We are also negotiating an agreement for the state of Tenn. with a group of Neurologists. New York may double our sales beginning in one month and we expect the same for Tennessee."

Inquiries can be made at

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Announces First Quarter 2009 is Profitable
2. ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech
3. ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09
4. ReBuilder Medical (RBRM) Neuropathy Market Doubles to $5 Billion
5. ReBuilder Medical Technologies, Inc. Appears Recession Proof
6. ReBuilder Medical Technologies, Inc. Says No to OTC - Rather Wait for NASDAQ
7. ReBuilder Medical Technologies, Inc. Seeks a Bigger and More Credible Equity Market - NASDAQ, here we come!
8. ReBuilder Medical Technologies, Inc. Reports 1st Quarter 2008 Sales Increase of Over 88%
9. ReBuilder Medical Technologies, Inc. Announces Top Sales Month - $410,000
10. ReBuilder Medical Technologies, Inc. Announces Best Sales Day in 5 Years
11. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
Post Your Comments:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: